Percepta -- Bioscience questions answered.Percepta -- Bioscience questions answered.Percepta -- Bioscience questions answered.
bioscience. questions. answered.

In US and Canada Call Toll Free: (877) 597-9236
Everywhere Else Call: (760) 431-6300

Blog

Life Scientist Opinions on GMO Labeling, Global Climate Change and Fossil Fuels

percepta

14th Jul, 2016

Blog

0

In a recent summary of the presumptive presidential nominees’ positions on issues related to science and the environment including GMO labeling, global climate change and fossil fuels, there was a clear dichotomy.  That is not likely to surprise many in an election year.  However, we were interested in seeing what actual scientists thought of these “Science and Environment” political issues.

Percepta polled…

read more >

Regulating Pharmaceutical Pricing – What the Scientists Say

percepta

9th Oct, 2015

Blog

0

In this campaign year, politicians have once again started to consider the issue of regulating pharmaceutical pricing policies.  It’s not a new concept but recent practices of certain pharmaceutical companies have given this topic new life.

An article in The New York Times on October 4th reported on several pharmaceutical companies that were buying existing patented therapeutic drugs and dramatically…

read more >

HIV testing – prevalent CLIA waived tests

percepta

12th Mar, 2015

Blog

1

Approximately 570 diagnostic tests and testing systems have been approved by the FDA for exclusion from regulation under CLIA criteria.  These tests are referred to as CLIA waived tests.

Roughly 4% of all CLIA waived tests in existence in the United States are HIV tests or test systems. Though all CLIA waived tests, including HIV tests, are designed to be…

read more >

CLIA Lab Genetic Testing Platforms – See the Score Card

percepta

27th Feb, 2015

Blog

0

The Centers for Medicare & Medicaid Services (CMS) regulates all non-research laboratory testing performed on humans in the U.S. through the 1988 Clinical Laboratory Improvement Amendments (or CLIA for short). Many of the tests performed are genetic tests that assess DNA and/or RNA.  For years this amounted mostly to PCR and blotting methods.  However, more and more clinical labs…

read more >

Epigenome Roadmap of Gene Switches Published

percepta

19th Feb, 2015

Blog

0

A slew of papers focused on an epigenome roadmap and the nature of gene regulation were published this week, highlighting the increasing importance of understanding not just genes but the switches that control them.  The focused effort of more than 200 scientists that authored the publications was the topic of a New York Times article today. Understanding the organization of…

read more >

Top Laboratory Practices in the Life Sciences

percepta

23rd Jan, 2015

Blog

0

It feels like we all know that there are certain laboratory practices that are common in most life science labs but how well do we know the list?  Percepta polled over 1,000 global scientists to find out the relative usage of 11 techniques used in life science laboratories.  While there may have been some shifting of the rank order,…

read more >

Mobile Devices Used More by Life Scientists to Share Opinions

percepta

9th Jan, 2015

Blog

0

Smart mobile devices have changed our lives and we now walk around with the internet in our back pockets.   They help us shop, share information, and update our favorite social media profiles.   However, how people use mobile devices tends to vary depending on the task at hand (pun intended).  Many find their mobile devices to be useful in the…

read more >

NIH Government Funding for 2014 Restored…Mostly

Mason Brooks

3rd Mar, 2014

Blog, News

0

On February 10th, 2014 the National Institutes of Health (NIH) released details about its fiscal mandates for the year. President Obama signed the Consolidated Appropriations Act (Public Law 113-76) into law on January 17th 2014, ensuring funding to NIH for the fiscal year ending September 30th, 2014.

The Act provides NIH with a budget of $30.15 billion, which is an increase…

read more >

Synthetic Biology Building Momentum with Researchers

Mason Brooks

31st Jan, 2014

Blog, Polls

0

With the explosion of biological data now available as a direct result of genome sequencing initiatives, use of commercial gene synthesis and pre-designed synthetic biology tools is becoming increasingly popular. We wanted to understand how molecular cloners feel about using synthetic biology tools as replacements for in-house methods such as cloning. So, in December 2013, we polled users of…

read more >

Copyright © 2017 Percepta Associates Inc. All rights reserved. Terms & Conditions.Designed by Audacity